Brief Summary

Skip to Participation Criteria

Official Title: "Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey"

A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

• Study Type: Observational
• Study Design: Observational Model: Cohort, Time Perspective: Prospective

Arms, Groups and Cohorts in this Clinical Trial

• 1
  • Patients with bipolar disorder

Outcome Measures for this Clinical Trial

Primary Measures

• Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
  • Safety Issue?: No

Secondary Measures

• Evaluation of the time period that elapsed since the diagnosis of bipolar disorder
  • Safety Issue?: No
• Evaluation of co-morbid psychiatric diseases
  • Safety Issue?: No
• Identification of treatment modalities selected according to the disease phase
  • Safety Issue?: No
• Identification of the number of first degree relatives diagnosed with bipolar disorder
  • Safety Issue?: No
• Evaluation of the relationship between patient and disease characteristics
  • Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria

• Patients previously or currently diagnosed with bipolar disorder
• Patients (or any of their relatives) who give a written informed consent.

Exclusion Criteria

• Patients who were previously included in this study.

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial: No

Clinical Trial Investigator Information

• Lead Sponsor
  • AstraZeneca
• Overall Official(s)
  • Mustafa Bilici, MD, Assoc. Prof, Study Director, Erenkoy State Hospital for Psychiatric Diseases, Istanbul, Turkey